Skip to content

Clinical trials

Phase 1 Glioblastoma trials in Switzerland

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Glioblastoma Phase: Phase 1 Country / region: Switzerland Clear all

13 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20041
20091
20111
20141
20161
20182
20191
20211
20222
20231
20241

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed7
Active, not recruiting2
Recruiting2
Terminated1
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
European Organisation for Research and Treatment of Cancer - EORTC2
Novartis Pharmaceuticals2
Sabine Mueller, MD, PhD2
Celgene1
EMD Serono Research & Development Institute, Inc.1
Hoffmann-La Roche1
Immatics Biotechnologies GmbH1
Mundipharma Research Limited1
University Hospital, Basel, Switzerland1
University Hospital, Geneva1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Glioblastoma13
Astrocytoma4
Glioma4
Brain Neoplasms2
Central Nervous System Neoplasms2
Ependymoma2
Gliosarcoma2
Oligodendroglioma2
Diffuse Intrinsic Pontine Glioma1
Esophageal Neoplasms1

Trials

Showing 1 to 13 of 13. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.